Skip to main content

Kovack Advisors, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1728321 FT. LAUDERDALE, FL

Position in REGN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$572,526
+$185,820 QoQ
Shares Held
741
+47.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Kovack Advisors, Inc. holds $5,306,795 across 13 Biotechnology names. REGN ranks #3 (10.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 REGN
Regeneron Pharmaceuticals, Inc.
This page
741 $572,526

All Filings in REGN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $572,526 741
2025-12-31 $386,706 501
2025-09-30 $215,349 383
2025-03-31 $211,198 333
2024-12-31 $229,370 322
2024-09-30 $338,499 322
2024-06-30 $348,941 332
2024-03-31 $319,546 332
2023-12-31 $291,592 332
2023-09-30 $275,691 335
2023-06-30 $236,399 329
2023-03-31 $312,234 380
2022-12-31 $234,484 325
2022-09-30 $230,771 335
2022-06-30 $670,341 1,134
2022-03-31 $1,155,885 1,655
2021-12-31 $867,076 1,373
2021-09-30 $896,271 1,481
2021-06-30 $220,623 395
2020-06-30 $227,632 365